SCHEMBL552268

SCHEMBL552268

CC1(C)OB(c2cccc(CNC(=O)C3CCCC3)c2)OC1(C)C

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.51
HPGD P15428 2/20 0.51
USP2 O75604 1/20 0.51
ERCC1 P07992 1/20 0.50
ERCC4 Q92889 1/20 0.50
LPL P06858 1/20 0.46
LIPG Q9Y5X9 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
WDR5 P61964 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
HSD17B10 Q99714 1/20 0.42
PKM P14618 2/20 0.42
ALOX12 P18054 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL553653 0.98 ALDH1A1 (0.54) ALDH1A1HPGDUSP2ERCC1ERCC4
SCHEMBL553260 0.95 LIPG (0.48) ALDH1A1HPGDUSP2ERCC1ERCC4
SCHEMBL552918 0.87 NPSR1 (0.48) ALDH1A1MEN1KMT2ASMN1; SMN2PKM
SCHEMBL171732 0.81 LIPG (0.53) ALDH1A1HPGDLPLLIPGKMT2A
SCHEMBL12523750 0.81 LIPG (0.53) ALDH1A1HPGDLPLLIPGMEN1
SCHEMBL13221145 0.80 F2 (0.42) ALDH1A1USP2LPLLIPGMEN1
SCHEMBL3212986 0.80 CA1 (0.54) ALDH1A1HPGDUSP2ERCC1ERCC4
SCHEMBL23732881 0.79 LIPG (0.51) ALDH1A1HPGDLPLLIPGSMN1; SMN2
SCHEMBL3189084 0.79 LIPG (0.54) ALDH1A1HPGDLPLLIPGSMN1; SMN2
SCHEMBL13242475 0.79 ALDH1A1 (0.56) ALDH1A1MEN1KMT2ASMN1; SMN2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8354406-B2 Chemical compounds GLAXOSMITHKLINE LLC (US) 2013-01-15 US disclosed
US-8288536-B2 Kinase inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-10-16 US disclosed
US-8288536-B2 Kinase inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-10-16 US disclosed
US-20120035164-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC 2012-02-09 US disclosed
US-8063071-B2 Chemical compounds GlaxoSmithKline, LLC (US) 2011-11-22 US disclosed
US-20100216765-A1 KINASE INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-08-26 US disclosed
US-20100216765-A1 KINASE INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-08-26 US disclosed
US-7713973-B2 Kinase inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-05-11 US disclosed
US-7713973-B2 Kinase inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-05-11 US disclosed
US-20090143372-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC 2009-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035164-A1 CHEMICAL COMPOUNDS IKBKG, NFKBIA, RELA ALDH1A1 2634/4885HPGD 1795/4885USP2 110/4885
US-20100216765-A1 KINASE INHIBITORS MAP3K20, MAP3K19, MAP3K1 ALDH1A1 4068/4885HPGD 2430/4885USP2 1493/4885
US-20090143372-A1 CHEMICAL COMPOUNDS IKBKG, NFKBIA, RELA ALDH1A1 2634/4885HPGD 1795/4885USP2 110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.